Pascal Qian Appointed General Manager of BMS China Unit
Pascal Qian this week officially assumed the role of General Manager of Bristol-Myers Squibb’s (BMS;...
NASDAQ: LIAN
LianBio Board Turns Down Concentra Biosciences Buyout Offer
China-based LianBio (OTCMKTS: LIANY) has announced that its board of directors has unanimously decided not...
BMS Regains Full Rights to Mavacamten in China and Asia from LianBio
Bristol-Myers Squibb (BMS; NYSE: BMY) is set to regain full control of mavacamten, a treatment...